How Does Diabetes Affect Wound Healing?

Health & Lifestyle
619

Translate to Spanish or other 102 languages!

A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection. Image for illustration purposes
A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection. Image for illustration purposes

Medical News Today

- Advertisement -

In people with diabetes, wounds can take longer to heal. These wounds often appear on the feet and legs. This slow healing can increase the risk of developing infections and other complications.

A person who manages their diabetes well can improve the rate at which wounds heal and reduce the likelihood of a severe infection.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/320739

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Take Precautions When Venturing Outside
Next article
Instructor Gives Hope to Aspiring Health Care Professionals

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -